The Eczema Area and Severity Index (EASI): Assessment of Reliability in Atopic Dermatitis. EASI Evaluator Group

Overview

Journal Exp Dermatol

Specialty Dermatology

Date 2001 Feb 13

PMID 11168575

Citations 336

Authors

J M Hanifin

M Thurston

M Omoto

R Cherill

S J Tofte

M Graeber

Affiliations

Soon will be listed here.

Abstract

Objective: To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency.

Design: Training of evaluators, application, and assessment over 2 consecutive days.

Setting: An academic center.

Patients: Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients > or = 8 years) and cohort 2 (10 patients < 8 years).

Interventions: None.

Main Outcome Measure: The EASI was used by 15 dermatologist evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed.

Results: Overall intra-evaluator reliability of the EASI was in the fair-to-good range. Inter-evaluator reliability analyses indicated that the evaluators assessed the patients consistently across both study days.

Conclusions: This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.

Citing Articles

Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study.

Galletta F, Rizzuti L, Passanisi S, Rosa E, Caminiti L, Manti S J Pers Med. 2025; 15(2).

PMID: 39997341 PMC: 11855966. DOI: 10.3390/jpm15020064.

Validation of the Atopic Dermatitis Control Tool (ADCT) and a Comparison with the Recap of Atopic Eczema Questionnaire (RECAP).

Zhang J, Miltner L, Loman L, Ragamin A, Oosterhaven J, Schuttelaar M Acta Derm Venereol. 2025; 105:adv42364.

PMID: 39964213 PMC: 11848947. DOI: 10.2340/actadv.v105.42364.

Lebrikizumab vs Other Systemic Monotherapies for Moderate-to-Severe Atopic Dermatitis: Network Meta-analysis of Efficacy.

Silverberg J, Bieber T, Paller A, Beck L, Kamata M, Puig L Dermatol Ther (Heidelb). 2025; 15(3):615-633.

PMID: 39953372 DOI: 10.1007/s13555-025-01357-7.

Differential Expression of Proteins Involved in Skin Barrier Maintenance and Vitamin D Metabolism in Atopic Dermatitis: A Cross-Sectional, Exploratory Study.

Grieco T, Paolino G, Moliterni E, Chello C, Sernicola A, Egan C Int J Mol Sci. 2025; 26(1.

PMID: 39796069 PMC: 11719518. DOI: 10.3390/ijms26010211.

Skin image analysis for detection and quantitative assessment of dermatitis, vitiligo and alopecia areata lesions: a systematic literature review.

Kallipolitis A, Moutselos K, Zafeiriou A, Andreadis S, Matonaki A, Stavropoulos T BMC Med Inform Decis Mak. 2025; 25(1):10.

PMID: 39780145 PMC: 11707889. DOI: 10.1186/s12911-024-02843-2.